WHO-GMP Certified Commercial Pack · Product Code: AKP-049-AV
Oseltamivir Capsules IP 45 mg
Formulation Overview: Potent oral neuraminidase inhibitor antiviral capsule (45 mg oseltamivir phosphate) arresting influenza A & B virion shedding and accelerating recovery when initiated within 48 hours of symptom onset. Formulated with Oseltamivir IP 45 mg (45 mg) in Hard Gelatin Capsules dosage form under Antiretrovirals / Antivirals, manufactured to IP / BP / USP Compendial standards and supplied in 10 x 10 Alu-Alu Blister Pack with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-049-AV |
|---|---|
| Catalog Reference | AKP-049 · SN 49 |
| Therapeutic Sector | Antiretrovirals / Antivirals |
| Dosage Form | Hard Gelatin Capsules |
| Active Ingredient | Oseltamivir IP 45 mg |
| Strength / Purity | 45 mg |
| Clinical Indication | Treatment and post-exposure prophylaxis of acute Influenza A and B viral infections (listed under Antiretrovirals / Antivirals sector per master product schedule) |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | 10 x 10 Alu-Alu Blister Pack |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C in a dry place, protect from light and moisture |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |